Skip to content
Agentic OS
Menu

Intelligence / Healthtech / New Clinical Trials / FASTEN

Clinicaltrial registered21 Oct 2026

FASTEN

21 Oct 2026: Trial registered · Fasten Onco Digital Therapy During Neoadjuvant Treatment for Triple-Negative Breast Cancer. Recorded in the ClinicalTrials.gov (US National Library of Medicine).

View the source record

Posted
21 Oct 2026
Title
Fasten Onco Digital Therapy During Neoadjuvant Treatment for Triple-Negative Breast Cancer
Conditions
Triple-Negative Breast Cancer (TNBC)
Phase
Not applicable
Study Type
Interventional
Status
Not Yet Recruiting
Countries
France
Country
France
Reference
NCT07884721
Location
France
What this signal means

A new trial needs sites, patients, data capture, monitoring and regulatory partners for years.

  1. United States leads with 192 of 777, then China (171).
  2. 777 added in the 30 days to 18 Nov 2026.
Reach them with AOS

Find the decision makers at FASTEN

AOS maps the buying committee, finds verified work emails and drafts outreach that cites this clinical signal, for your approval.

Start free

More from France

New Clinical Trials

See all

Source: ClinicalTrials.gov (US National Library of Medicine), data to 18 Nov 2026. Trials first posted in the window whose lead sponsor is a company, worldwide. Device and diagnostic studies usually have no phase. AOS shows what the public record says; it does not verify or endorse the company.